SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-18-008650
Filing Date
2018-11-06
Accepted
2018-11-06 16:42:21
Documents
62
Period of Report
2018-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q knsa-20180930x10q.htm 10-Q 2158043
2 EX-31.1 knsa-20180930ex3118fee6e.htm EX-31.1 12483
3 EX-31.2 knsa-20180930ex31280231d.htm EX-31.2 11360
4 EX-32.1 knsa-20180930ex32175d9bf.htm EX-32.1 7149
5 EX-32.2 knsa-20180930ex32209fea0.htm EX-32.2 7037
  Complete submission text file 0001558370-18-008650.txt   7043619

Data Files

Seq Description Document Type Size
6 EX-101.INS knsa-20180930.xml EX-101.INS 1273884
7 EX-101.SCH knsa-20180930.xsd EX-101.SCH 51320
8 EX-101.CAL knsa-20180930_cal.xml EX-101.CAL 34544
9 EX-101.DEF knsa-20180930_def.xml EX-101.DEF 268674
10 EX-101.LAB knsa-20180930_lab.xml EX-101.LAB 466209
11 EX-101.PRE knsa-20180930_pre.xml EX-101.PRE 379325
Mailing Address CLARENDON HOUSE 2 CHURCH STREET HAMILTON D0 HM11
Business Address CLARENDON HOUSE 2 CHURCH STREET HAMILTON D0 HM11 7814399100
Kiniksa Pharmaceuticals, Ltd. (Filer) CIK: 0001730430 (see all company filings)

IRS No.: 000000000 | State of Incorp.: D0 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38492 | Film No.: 181163559
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1